XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Deficit
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Deficit
Under the authority of our Board of Directors, we repurchased shares of our Common Stock during the years ended June 30, 2023 and 2022 as indicated below.  All amounts exclude applicable transaction fees. 

 Shares Repurchased
(thousands)
Dollar Value of Shares
Repurchased
Remaining Dollar Value of Shares that may be Repurchased
Authorization Date2023202220232022
2023
May 2021— 4,635 — 557 — 
September 2022387 — 50 — 1,700 
Total387 4,635 

$50 $557 

$1,700 

In September 2022, our Board of Directors authorized share repurchases of up to $2 billion (excluding applicable transaction fees) of our outstanding Common Stock through June 30, 2024. As of June 30, 2023, we have remaining capacity to repurchase up to $1.7 billion of Common Stock under the September 2022 authorization.
Changes in Accumulated other comprehensive loss (“AOCI”) are presented below.
Translation Adjustments and Gains (Losses) From Intra-Entity Transactions of a Long-Term NaturePension and Post-Retirement BenefitsDerivative InstrumentsTotal
Balance at March 31, 2023, net of tax
$(282)$(96)$$(371)
OCI, net of tax
Gains (losses) arising during the period classified into AOCI, net of tax
— 19 23 
(Gains) losses reclassified from AOCI, net of tax
60 (6)55 
64 13 78 
Balance at June 30, 2023, net of tax
$(218)$(95)$20 $(293)
Balance at December 31, 2022, net of tax$(290)$(94)$15 $(369)
OCI, net of tax
Gains (losses) arising during the period classified into AOCI, net of tax
12 (2)13 23 
(Gains) losses reclassified from AOCI, net of tax
60 (8)53 
72 (1)76 
Balance at June 30, 2023, net of tax$(218)$(95)$20 $(293)